Home » Intellectual Property

Technology Transfer

The Economic Contribution of University/Nonprofit Inventions in the United States: 1996-2010

Using an input output “I-O” approach to estimating the economic impact of academic licensing, and summing over the 15 years of available data for academic U.S. AUTM Survey respondents, the total contribution of these academic licensors to gross industry output ranges from $199B to $836B, in 2005 $US Dollars; contributions to GDP range from $86B to $388B, in 2005 $US Dollars.

Taking Stock: How Global Biotechnology Benefits from Intellectual Property Rights

This report examines the role played by IPRs in both upstream and downstream phases of the research, development and commercialization of biotechnology products and provides a review and analysis of the existing body of knowledge concerning the role of IPRs.

Case Studies for Global Health: Case Studies Focus on Role of Multi-Sector Collaborations to Address Global Health Challenges

Successful multi-sector global health programs engage partners and policymakers early, communicate openly and frequently with relevant stakeholders, and empower and involve communities, according to a website relaunched this week, Case Studies for Global Health.

Bringing Innovation to Neglected Disease Research and Development: Joint Report by BIO and BIO Ventures for Global Health

BIO Ventures for Global Health (BVGH) and the Biotechnology Industry Organization (BIO) have collaborated on a new report that builds upon the findings in BVGH’s previous analysis, Developing New Drugs and Vaccines for Neglected Diseases of the Poor: The Product Developer Landscape.

Enhancing America’s Competitive Edge

While the U.S. leads in the area of biotechnology, there is no guarantee this competitive edge will continue.

Bayh-Dole: Technology Transfer Survey Summary Conclusions

The purpose of this survey was to examine technology transfer and licensing practices by biotechnology companies and determine its importance to the industry.

BIO 2009 MEMBER SURVEY TECHNOLOGY TRANSFER AND THE BIOTECHNOLOGY INDUSTRY

The purpose of this survey was to examine the extent and importance of technology transfer and licensing activity involving biotechnology companies.

Bayh-Dole: BIO Study on the Economic Impact of Licensed Commercialized Inventions Originating in University Research

The study provides first-of-its-kind data on the importance of university/industry research and development partnerships to the U.S. economy.

The Economic Impact of Licensed Commercialized Inventions Originating in University Research, 1996-2007
Technology Transfer: Benefits from Biotech

This side-event, organized by the Biotechnology Industry Organization (BIO) and cosponsored by the Association of University Technology Managers (AUTM), provided an overview on the key elements at play in establishment an enabling environment for transfer of technology to support the full implementation of CBD objectives and priorities.

Letters, Testimony & Comments

2012 Special 301 Report: Biotech's International IP Issues
February 14 2012
BIO has identified the following countries of interest and recommends the following for our 2011 Special 301 submission. Priority...
Biotech Leader Provides Testimony at Congressional Hearing on SBIR/STTR Renewal
April 7 2011
Hearing Testimony Scott Koenig, M.D., PH.D. Before the House of Representatives Committee on Small Business Good morning Chairman...
Bayh-Dole: Access to Early Capital Paper
May 27 2010
Access to Early Capital In the United States and globally, commercial development of biotechnology relies on the continuing...
Technology Transfer: BIO Comments to Office of Science and Technology Policy on Commercialization of University Research
May 25 2010
The Biotechnology industry Organization appreciates the opportunity to respond to the Request for Information issued by the Office of...
GAO Report to Congress: Information on the Government’s Right to Assert Ownership Control over Federally Funded Inventions
July 1 2009
More Letters, Testimony & Comments →

Press Releases

Joint Statement of BIO, AAU, ACE, APLU, AUTM and COGR on the Supreme Court Decision in Stanford v. Roche
June 6 2011
WASHINGTON, D.C. (Tuesday, June 06, 2011) - Today, the United States Supreme Court issued its opinion in the appeal...
Biotech Leader Provides Testimony at Congressional Hearing on SBIR/STTR Renewal
April 7 2011
WASHINGTON, D.C. (Thursday, April 07, 2011) - Today, the House Subcommittee on Healthcare and Technology will hold a...
Senate Small Business Committee Reinstates Limited SBIR Grant Eligibility for Firms Majority-Backed by Venture Capital
July 30 2008
WASHINGTON, D.C. (Wednesday, July 30, 2008) - Small businesses that are majority-backed by venture capital, many...
Milken Institute Study Confirms Vital Role of Technology Transfer in Biotechnology Globally, Says BIO
September 20 2006
WASHINGTON, D.C. (September 20, 2006) –The Milken Institute study released today entitled “Mind-to-Market...
Technology Transfer Forum at BIO 2002 in Toronto
May 30 2002
 WASHINGTON, D.C. (May 30, 2002) – The Biotechnology Industry Organization’s (BIO) annual meeting,...